604 related articles for article (PubMed ID: 28764328)
1. Protospacer Adjacent Motif-Induced Allostery Activates CRISPR-Cas9.
Palermo G; Ricci CG; Fernando A; Basak R; Jinek M; Rivalta I; Batista VS; McCammon JA
J Am Chem Soc; 2017 Nov; 139(45):16028-16031. PubMed ID: 28764328
[TBL] [Abstract][Full Text] [Related]
2. Conformational control of DNA target cleavage by CRISPR-Cas9.
Sternberg SH; LaFrance B; Kaplan M; Doudna JA
Nature; 2015 Nov; 527(7576):110-3. PubMed ID: 26524520
[TBL] [Abstract][Full Text] [Related]
3. DNA interrogation by the CRISPR RNA-guided endonuclease Cas9.
Sternberg SH; Redding S; Jinek M; Greene EC; Doudna JA
Nature; 2014 Mar; 507(7490):62-7. PubMed ID: 24476820
[TBL] [Abstract][Full Text] [Related]
4. Bidirectional Degradation of DNA Cleavage Products Catalyzed by CRISPR/Cas9.
Stephenson AA; Raper AT; Suo Z
J Am Chem Soc; 2018 Mar; 140(10):3743-3750. PubMed ID: 29461055
[TBL] [Abstract][Full Text] [Related]
5. Cas9, Cpf1 and C2c1/2/3-What's next?
Nakade S; Yamamoto T; Sakuma T
Bioengineered; 2017 May; 8(3):265-273. PubMed ID: 28140746
[TBL] [Abstract][Full Text] [Related]
6. Inhibition Mechanism of an Anti-CRISPR Suppressor AcrIIA4 Targeting SpyCas9.
Yang H; Patel DJ
Mol Cell; 2017 Jul; 67(1):117-127.e5. PubMed ID: 28602637
[TBL] [Abstract][Full Text] [Related]
7. Leveraging QM/MM and Molecular Dynamics Simulations to Decipher the Reaction Mechanism of the Cas9 HNH Domain to Investigate Off-Target Effects.
Maghsoud Y; Jayasinghe-Arachchige VM; Kumari P; Cisneros GA; Liu J
J Chem Inf Model; 2023 Nov; 63(21):6834-6850. PubMed ID: 37877218
[TBL] [Abstract][Full Text] [Related]
8. Structural Basis for the Canonical and Non-canonical PAM Recognition by CRISPR-Cpf1.
Yamano T; Zetsche B; Ishitani R; Zhang F; Nishimasu H; Nureki O
Mol Cell; 2017 Aug; 67(4):633-645.e3. PubMed ID: 28781234
[TBL] [Abstract][Full Text] [Related]
9. Programmable RNA recognition and cleavage by CRISPR/Cas9.
O'Connell MR; Oakes BL; Sternberg SH; East-Seletsky A; Kaplan M; Doudna JA
Nature; 2014 Dec; 516(7530):263-6. PubMed ID: 25274302
[TBL] [Abstract][Full Text] [Related]
10. Cas9 specifies functional viral targets during CRISPR-Cas adaptation.
Heler R; Samai P; Modell JW; Weiner C; Goldberg GW; Bikard D; Marraffini LA
Nature; 2015 Mar; 519(7542):199-202. PubMed ID: 25707807
[TBL] [Abstract][Full Text] [Related]
11. CRISPR-Cas9 Structures and Mechanisms.
Jiang F; Doudna JA
Annu Rev Biophys; 2017 May; 46():505-529. PubMed ID: 28375731
[TBL] [Abstract][Full Text] [Related]
12. Real-time observation of DNA target interrogation and product release by the RNA-guided endonuclease CRISPR Cpf1 (Cas12a).
Singh D; Mallon J; Poddar A; Wang Y; Tippana R; Yang O; Bailey S; Ha T
Proc Natl Acad Sci U S A; 2018 May; 115(21):5444-5449. PubMed ID: 29735714
[TBL] [Abstract][Full Text] [Related]
13. Methods for decoding Cas9 protospacer adjacent motif (PAM) sequences: A brief overview.
Karvelis T; Gasiunas G; Siksnys V
Methods; 2017 May; 121-122():3-8. PubMed ID: 28344037
[TBL] [Abstract][Full Text] [Related]
14. Structures of a CRISPR-Cas9 R-loop complex primed for DNA cleavage.
Jiang F; Taylor DW; Chen JS; Kornfeld JE; Zhou K; Thompson AJ; Nogales E; Doudna JA
Science; 2016 Feb; 351(6275):867-71. PubMed ID: 26841432
[TBL] [Abstract][Full Text] [Related]
15. Programmable DNA cleavage in vitro by Cas9.
Karvelis T; Gasiunas G; Siksnys V
Biochem Soc Trans; 2013 Dec; 41(6):1401-6. PubMed ID: 24256227
[TBL] [Abstract][Full Text] [Related]
16. Probing the structural dynamics of the CRISPR-Cas9 RNA-guided DNA-cleavage system by coarse-grained modeling.
Zheng W
Proteins; 2017 Feb; 85(2):342-353. PubMed ID: 27936513
[TBL] [Abstract][Full Text] [Related]
17. Structural Basis for Reduced Dynamics of Three Engineered HNH Endonuclease Lys-to-Ala Mutants for the Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR)-Associated 9 (CRISPR/Cas9) Enzyme.
Wang J; Skeens E; Arantes PR; Maschietto F; Allen B; Kyro GW; Lisi GP; Palermo G; Batista VS
Biochemistry; 2022 May; 61(9):785-794. PubMed ID: 35420793
[TBL] [Abstract][Full Text] [Related]
18. CRISPR/Cas9 for genome editing: progress, implications and challenges.
Zhang F; Wen Y; Guo X
Hum Mol Genet; 2014 Sep; 23(R1):R40-6. PubMed ID: 24651067
[TBL] [Abstract][Full Text] [Related]
19. Engineered CRISPR-Cas9 nucleases with altered PAM specificities.
Kleinstiver BP; Prew MS; Tsai SQ; Topkar VV; Nguyen NT; Zheng Z; Gonzales AP; Li Z; Peterson RT; Yeh JR; Aryee MJ; Joung JK
Nature; 2015 Jul; 523(7561):481-5. PubMed ID: 26098369
[TBL] [Abstract][Full Text] [Related]
20. An engineered ScCas9 with broad PAM range and high specificity and activity.
Chatterjee P; Jakimo N; Lee J; Amrani N; RodrÃguez T; Koseki SRT; Tysinger E; Qing R; Hao S; Sontheimer EJ; Jacobson J
Nat Biotechnol; 2020 Oct; 38(10):1154-1158. PubMed ID: 32393822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]